FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2066936475> ?p ?o ?g. }

• W2066936475 endingPage "89" @default.
• W2066936475 startingPage "81" @default.
• W2066936475 abstract "Administration of novel, versus classic, antipsychotic agents to patients suffering from psychosis is associated both with moderately better scores on cognitive tests, and with fewer extrapyramidal symptoms (EPS). Because improved motor functioning may enable better performance on some components of cognitive test batteries, and because the advantages of the novel antipsychotics on cognitive performance are not very large, it is sometimes difficult to discern if improvement in a given cognitive task is due to a direct effect of the novel antipsychotic drug, or is secondary to the novel drug's decreased propensity to induce EPS. In an attempt to distinguish between these two possibilities, the present study examined the ability of patients suffering from schizophrenia receiving classic, versus novel antipsychotics, to perform a computerized visuo-motor test (VMT). VMT assesses planning capabilities, attention and executive functions known to be impaired in schizophrenia, which are suggested to be affected by novel antipsychotics.Seventy-six patients suffering from schizophrenia or schizophreniform disorder, receiving haloperidol (23 patients, mean dose 10.01+/-6.1mg/day), olanzapine (26 patients, mean dose 10.56 +/- 4.9 mg/day) or risperidone (27 patients, mean dose 4.35 +/- 1.7 mg/day) were assessed for EPS using the parkinsonian subscale of the Extrapyramidal Symptom Rating Subscale (ESRS), and with the VMT.Cognitive functioning as measured by the VMT was better for patients receiving risperidone or olanzapine, compared with those receiving haloperidol (F=6.636, df=2,67, P=0. 002), while the patients receiving haloperidol or risperidone suffered from more severe EPS compared with the patients receiving olanzapine (F=3.996, df=2,71, P=0.023).Although the patients receiving risperidone suffered from EPS similar in severity to the EPS of the patients receiving haloperidol, their performance on a task involving visuo-motor and attentional skills was similar to that of the patients receiving olanzapine. This finding implies that there is a dissociation between the antipsychotic drug's ability to affect cognitive functioning, and EPS. This dissociation indirectly suggests that the advantages offered by novel antipsychotics on cognitive performance are a direct effect, rather than being entirely mediated by improved movement abilities." @default.
• W2066936475 created "2016-06-24" @default.
• W2066936475 creator A5021587962 @default.
• W2066936475 creator A5023164039 @default.
• W2066936475 creator A5024067064 @default.
• W2066936475 creator A5029155364 @default.
• W2066936475 creator A5055380940 @default.
• W2066936475 creator A5056204009 @default.
• W2066936475 creator A5074704408 @default.
• W2066936475 creator A5087352960 @default.
• W2066936475 date "2000-12-01" @default.
• W2066936475 modified "2023-10-18" @default.
• W2066936475 title "Improvement in cognition associated with novel antipsychotic drugs: a direct drug effect or reduction of EPS?" @default.
• W2066936475 cites W120301641 @default.
• W2066936475 cites W153750880 @default.
• W2066936475 cites W1657694742 @default.
• W2066936475 cites W168678988 @default.
• W2066936475 cites W1978962144 @default.
• W2066936475 cites W1983438437 @default.
• W2066936475 cites W1989275158 @default.
• W2066936475 cites W1989765954 @default.
• W2066936475 cites W1991864608 @default.
• W2066936475 cites W2003471045 @default.
• W2066936475 cites W2018345227 @default.
• W2066936475 cites W2021728160 @default.
• W2066936475 cites W2022765281 @default.
• W2066936475 cites W2036410804 @default.
• W2066936475 cites W2039664444 @default.
• W2066936475 cites W2054209782 @default.
• W2066936475 cites W2056212570 @default.
• W2066936475 cites W2063453860 @default.
• W2066936475 cites W2065226845 @default.
• W2066936475 cites W2070735132 @default.
• W2066936475 cites W2075557948 @default.
• W2066936475 cites W2082713532 @default.
• W2066936475 cites W2088527386 @default.
• W2066936475 cites W2090156827 @default.
• W2066936475 cites W2104402653 @default.
• W2066936475 cites W2106352416 @default.
• W2066936475 cites W2106823827 @default.
• W2066936475 cites W2132824773 @default.
• W2066936475 cites W2138270641 @default.
• W2066936475 cites W2140606211 @default.
• W2066936475 cites W2166938377 @default.
• W2066936475 cites W2171524950 @default.
• W2066936475 cites W2205215605 @default.
• W2066936475 cites W2345907171 @default.
• W2066936475 cites W2417733377 @default.
• W2066936475 cites W33021784 @default.
• W2066936475 cites W4245655064 @default.
• W2066936475 cites W4252542148 @default.
• W2066936475 doi "https://doi.org/10.1016/s0920-9964(00)00025-6" @default.
• W2066936475 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11120419" @default.
• W2066936475 hasPublicationYear "2000" @default.
• W2066936475 type Work @default.
• W2066936475 sameAs 2066936475 @default.
• W2066936475 citedByCount "34" @default.
• W2066936475 countsByYear W20669364752013 @default.
• W2066936475 countsByYear W20669364752016 @default.
• W2066936475 countsByYear W20669364752020 @default.
• W2066936475 countsByYear W20669364752022 @default.
• W2066936475 crossrefType "journal-article" @default.
• W2066936475 hasAuthorship W2066936475A5021587962 @default.
• W2066936475 hasAuthorship W2066936475A5023164039 @default.
• W2066936475 hasAuthorship W2066936475A5024067064 @default.
• W2066936475 hasAuthorship W2066936475A5029155364 @default.
• W2066936475 hasAuthorship W2066936475A5055380940 @default.
• W2066936475 hasAuthorship W2066936475A5056204009 @default.
• W2066936475 hasAuthorship W2066936475A5074704408 @default.
• W2066936475 hasAuthorship W2066936475A5087352960 @default.
• W2066936475 hasConcept C118552586 @default.
• W2066936475 hasConcept C126322002 @default.
• W2066936475 hasConcept C15744967 @default.
• W2066936475 hasConcept C169900460 @default.
• W2066936475 hasConcept C185711340 @default.
• W2066936475 hasConcept C2775870346 @default.
• W2066936475 hasConcept C2776412080 @default.
• W2066936475 hasConcept C2776619155 @default.
• W2066936475 hasConcept C2776921671 @default.
• W2066936475 hasConcept C2776978879 @default.
• W2066936475 hasConcept C2779727114 @default.
• W2066936475 hasConcept C2780057945 @default.
• W2066936475 hasConcept C2780494398 @default.
• W2066936475 hasConcept C2780616385 @default.
• W2066936475 hasConcept C2780948584 @default.
• W2066936475 hasConcept C513476851 @default.
• W2066936475 hasConcept C71924100 @default.
• W2066936475 hasConceptScore W2066936475C118552586 @default.
• W2066936475 hasConceptScore W2066936475C126322002 @default.
• W2066936475 hasConceptScore W2066936475C15744967 @default.
• W2066936475 hasConceptScore W2066936475C169900460 @default.
• W2066936475 hasConceptScore W2066936475C185711340 @default.
• W2066936475 hasConceptScore W2066936475C2775870346 @default.
• W2066936475 hasConceptScore W2066936475C2776412080 @default.
• W2066936475 hasConceptScore W2066936475C2776619155 @default.
• W2066936475 hasConceptScore W2066936475C2776921671 @default.
• W2066936475 hasConceptScore W2066936475C2776978879 @default.
• W2066936475 hasConceptScore W2066936475C2779727114 @default.

• next